Sentiment Change Report: Athenahealth Inc (NASDAQ:ATHN)

  • Sentiment Change Report: Athenahealth Inc (NASDAQ:ATHN)

Sentiment Change Report: Athenahealth Inc (NASDAQ:ATHN)

It has change of 0.30, from 2017Q4's 1. Flinton Capital Management LLC now owns 1,168 shares of the health services provider's stock valued at $167,000 after acquiring an additional 448 shares during the last quarter. (NASDAQ:ATHN). Franklin Res invested in 4,846 shares. Ftb Advisors reported 109 shs or 0% of all its holdings. (NASDAQ:ATHN). Gotham Asset Management Lc holds 28,750 shs. Finally, ARK Investment Management LLC boosted its holdings in shares of athenahealth by 55.5% during the 4th quarter. Twin Tree Mngmt Lp invested in 3,413 shs or 0% of the stock. (NASDAQ:ATHN). Germany-based Deutsche National Bank Ag has invested 0.01% in athenahealth, Inc. (NASDAQ:ATHN) or 150 shares. Federated Invsts Pa holds 67,580 shares. Vanguard Grp Inc invested in 0.02% or 3.31 million shs. (NASDAQ:ATHN) news brought out recently go to: Streetinsider.com, Bizjournals.com, Seekingalpha.com, Seekingalpha.com or Streetinsider.com. Federated Invsts Pa invested in 67,580 shares or 0.03% of the stock. JPMorgan Chase & Co. began coverage on shares of athenahealth in a research report on Tuesday, April 24th. 8,434 are held by Amalgamated State Bank.

Since January 2, 2018, it had 2 insider buys, and 23 sales for $12.40 million activity. 2,235 shares were sold by Armbrester Bradford Kyle, worth $309,995. (NASDAQ:ATHN) shares were bought by IMMELT JEFFREY R. Hull Brandon H sold 800 shares worth $107,896. On Thursday, March 1 the insider O'Brien Timothy John sold $420,596. (NASDAQ:ATHN) rating. JP Morgan has "Neutral" rating and $159 target. Citigroup's target price would indicate a potential upside of 5.86% from the stock's previous close. ValuEngine raised athenahealth from a "hold" rating to a "buy" rating in a research report on Tuesday, May 8th.

Ratings analysis reveals 29% of Athenahealth's analysts are positive. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.25. athenahealth has a 52 week low of $111.61 and a 52 week high of $158.66. The stock's average target of $157.67 is -6.26% below today's ($168.2) share price. Athenahealth had 27 analyst reports since December 8, 2017 according to SRatingsIntel. The firm has "Hold" rating given on Tuesday, May 8 by Leerink Swann. In Tuesday, May 22 report Deutsche Bank maintained the stock with "Hold" rating. In Friday, February 16 report Piper Jaffray maintained the stock with "Buy" rating. As a outcome of the price increase, athenahealth, Inc. now has a current market value of 6.41B. Loop Capital upgraded the stock to "Buy" rating in Thursday, February 1 report. The company rating was maintained by Oppenheimer on Wednesday, April 18. The company rating was maintained by Cantor Fitzgerald on Thursday, May 24. (NASDAQ:ATHN) with "Hold" rating. On Tuesday, May 8 the stock of athenahealth, Inc. The rating was maintained by Cantor Fitzgerald with "Hold" on Wednesday, February 7.

(ATHN) surged 4.17%, amounting to a gain of $6.3 per share, to finish the regular trading session at $157.44 on Wednesday 06/06/2018. (NASDAQ:ATHN) has risen 14.89% since June 6, 2017 and is uptrending. ATHN outperformed by 2.32% the S&P 500. The firm's revenue for the quarter was up 15.4% compared to the same quarter last year. sell-side analysts forecast that athenahealth will post 2.92 EPS for the current year. During the same period in the prior year, the company posted $0.34 earnings per share. CACI's profit will be $40.75 million for 25.48 P/E if the $1.65 EPS becomes a reality. Prominent athenahealth investor Elliott Management Corp.is offering about $6.5 billion to take the medical billing software maker private after saying it has grown frustrated with the company's performance. It has a 120.18 P/E ratio. The firm also provides athenahealth Population Health, a cloud population health service; and Epocrates services that include clinical information and decision support services in the areas of drug and disease information, medical calculator and tools, clinical guidelines, clinical messaging, and market research.

The departure marks an ignominious end at Athenahealth for Bush, 49, who helped create a software platform that serves more than 100,000 medical providers. "As the company explores alternatives, I'm sure there will be multiple financial sponsors interested in taking a look, and Cerner is a logical strategic option", she notes, adding that Cerner has publicly stated their lack of interest in athenahealth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.